News

PATH/Patrick McKern
GHTC sends letter of support for National Biodefense Strategy

GHTC sent a letter to Secretary of Health and Human Services Alex Azar in support of the National Biodefense Strategy released by the Administration in September. The letter commends the goals in the strategy aimed at accelerating basic and applied R&D of new antimicrobials, novel therapeutics, vaccines, and diagnostic tests; promoting increased global capacities for R&D, and integrating R&D into federal planning before and during a potential bio-incident.

PDF
PATH/Lynn Heinisch
GHTC welcomes the Administration recommitment to GHSA

GHTC joined other global health organizations in sending a letter to Secretary of Health and Human Services Alex Azar welcoming the Administration's recommitment to the Global Health Security Agenda (GHSA) and urging the Administration to provide robust funding for global health security activities in the fiscal year (FY) 2020 budget and release the Global Health Security Strategy required by Congress in the FY18 appropriations omnibus.

PDF
PATH/Gabe Bienczycki
GHTC sends FY20 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2020 (FY20) budget.

PDF
PATH/Gabe Bienczycki
GHTC signs letter to House and Senate appropriators supporting global health programs in FY19 budget

GHTC endorsed a letter from the Global Health Council urging House and Senate appropriators to provide robust funding for global health programs in the fiscal year 2019 State and Foreign Operations and Labor, Health and Human Services spending bills as they conference each chambers’ respective bills.

PDF
PATH/Matt Steele
GHTC sends letter of support for House PAHPA bill

GHTC sent a letter to members of the House of Representatives in support of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (H.R. 6378) (PAHPA), commending the inclusion of specific provisions and dedicated funding to advance the development of medical countermeasures to address emerging infectious diseases and pandemic influenza.

PDF
PATH/Aaron Joel Santos
GHTC launches petition calling on world leaders to include R&D in the Global Health Security Agenda

GHTC launched a new online petition calling on world leaders to include clear commitments to strengthening R&D capacity in the 2019-2024 Global Health Security Agenda framework, which is currently under development.

View
PATH/Nguyen Ba Quang
GHTC sends letter urging House leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the House Energy and Commerce Committee encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.

PDF
Flickr/Craig Fildes
GHTC submits FY19 testimony to Senate appropriators

GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget. 

Learn More
PATH/Katrina Peach
GHTC statement on TB high-level meeting delivered at WHA

A statement by GHTC and partners calling for the United Nations High-Level Meeting on Ending TB to issue a political declaration focused on increasing investments in tuberculosis (TB) R&D was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, Infectious Diseases Society of America, Elizabeth Glaser Pediatric AIDS Foundation, and Partners in Health, also encourages the inclusion of child-specific targets for TB R&D and additional resources for R&D to combat drug-resistant TB.

PDF
PATH/Eric Becker
GHTC statement on access to medicines delivered at WHA

A statement by GHTC and partners calling for the World Health Organization to support a comprehensive approach to addressing barriers to access to medicines was delivered at the 71st World Health Assembly (WHA). The statement, which was prepared in partnership with Global Health Council, American Academy of Pediatrics, NCD Child, and the International Federation of Psoriasis Associations, notes the importance of strengthening regulatory systems and harmonizing processes.

PDF
PATH/Aaron Joel Santos
GHTC issues statement on access to medicines at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session encouraging the US delegation to support a comprehensive approach to addressing barriers to accessing essential medicines. The statement notes the importance of strengthening regulatory systems and harmonizing processes, as well as encourages the US to support the World Health Organization in better leveraging the expertise of product development partnerships in securing sustainable access comitments. 

PDF
PATH/Gabe Bienczycki
GHTC sends letter urging Senate leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the Health, Education, Labor and Pensions Committee (HELP) encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.

PDF
PATH/Will Marlow
GHTC submits FY19 testimony to House appropriators

GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.

Learn More
University of Maryland Institute of Human Virology
GHTC welcomes Robert Redfield as CDC director

GHTC sent a letter welcoming Dr. Robert Redfield as the new Centers for Disease Control and Prevention (CDC) director and urging him to prioritize global health R&D at CDC.

PDF
Flick/David
GHTC sends FY19 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget.

Learn More
PATH/Patrick McKern
GHTC welcomes Alex Azar as HHS Secretary

GHTC sent a letter welcoming Alex Azar as the new Secretary of Health and Human Services (HHS), urging him to prioritize global health R&D efforts at HHS.

PDF
PATH/Patrick McKern
GHTC sends letter expressing concern about reported cuts to CDC GHSA activities

GHTC jointly with other civil society organizations sent a letter raising concerns over recent reports that the US Centers for Disease Control and Prevention (CDC) plans to dramatically scale back its activities to support the Global Health Security Agenda (GHSA). The letter notes the vital role of this program in promoting global health security and protecting the health and national security of Americans.

PDF
GHTC issues statement on R&D for public health preparedness at WHO Executive Board meeting

GHTC issued a statement at the 142nd session of the World Health Organization (WHO) Executive Board welcoming efforts by WHO to advance the Research and Development Blueprint for Action to Prevent Epidemics, which is integral part of ensuring the global community has to right tools to prevent and combat epidemics. The statement was issued in partnership with the Global Health Council, PATH, the American Academy of Pediatrics, and the Infectious Disease Society of America.

PDF
United States Mission Geneva
GHTC calls for further consultations on WHO prequalification fee changes

GHTC joined with other members of the global health community to call for consultations to resolve ongoing concerns around adjustments to the World Health Organization (WHO) prequalification fees for medicines and diagnostics.

PDF
Architect of the Capitol
GHTC urges Congress to raise non-defense discretionary spending caps to allow sustained funding for global health

GHTC joined with other members of the global health community in sending a letter to Congressional leaders urging them to raise the non-defense discretionary spending cap as part of fiscal year 2108 budget deal negotiations to allow sustained funding for global health programs through the International Affairs (Function 150) and Health (Function 550) accounts.

PDF
GHTC
GHTC sends letter urging House Armed Services Committee Chairman to oppose provisions in Defense Authorization Act that would threaten global health research

GHTC sent a letter to House Armed Services Committee Chairman Mac Thornberry urging him, as the fiscal year 2018 National Defense Authorization Act undergoes House and Senate conference, to oppose provisions in the Senate bill that would threaten global health research at the US Department of Defense.

PDF
GHTC
GHTC welcomes new WHO Assistant Director General Dr. Simão

GHTC sent a letter welcoming new World Health Organization (WHO) Assistant Director General Dr. Mariângela Batista Galvão Simão and encouraging further action by WHO to foster an enabling environment for global health R&D.

PDF
GHTC
GHTC sends FY19 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2019 (FY19) budget.

PDF
US Agency for International Development
GHTC welcomes Mark Green as USAID administrator

GHTC sent a letter welcoming incoming Administrator of the US Agency for International Development (USAID) Mark Green, highlighting the agency’s work on global health R&D and urging him to continue to support this work as administrator.

PDF
Photo by Tedx Atlanta/via Flickr
GHTC welcomes Brenda Fitzgerald as CDC director

GHTC sent a letter welcoming Dr. Brenda Fitzgerald as the new Centers for Disease Control and Prevention (CDC) director, urging her to prioritize global health R&D at CDC.

PDF
http://www.who.int/dg/en/
GHTC welcomes new WHO Director General Dr. Tedros

GHTC sent a letter welcoming World Health Organization (WHO) Director General Dr. Tedros Adhanom Ghebreyesus and urging him to to focus on R&D as a central aspect of WHO's efforts to advance global health.

PDF
GHTC submits input on TB Ministerial Meeting Zero Draft

GHTC submitted input to the online consultation on the Zero Draft of the Declaration proposed for the Global Ministerial Conference on Ending Tuberculosis in the Sustainable Development Era expressing strong support for the draft language and calling on drafters to ensure that future versions retain strong support for innovation and R&D as core components of combating tuberculosis (TB).

PDF
GHTC, partners issue letter to G20 heads of state urging action to address global health challenges

GHTC joined 33 leading global health organizations and members of national parliaments in issuing an open letter to G20 heads of state, calling for them to increase the prioritization of health by the G20, establish the G20 as a permanent global health policy forum, and continue the strong focus on R&D to address critical challenges like emerging and drug-resistant infectious diseases.

PDF
GHTC, PATH, GHC
GHTC delivers statement on WHO R&D observatory, pooled fund at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) calling for the rapid operationalization and full funding for the World Health Organization Global Observatory on Health Research and Development and supporting efforts to establish a health R&D pooled fund. The statement, which was issued in partnership with the Global Health Council and PATH, also encourages exploration of innovative funding sources to attract new funding for the observatory and pooled fund and calls for continued transparency to ensure these operations are grounded in sound science and public health.

PDF
GHTC, GHC, PATH, American Academy of Pediatrics
GHTC delivers statement on antimicrobial resistance at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) welcoming global political commitments to combat antimicrobial drug resistance (AMR) and calling for these efforts to prioritize R&D for new tools. The statement, which was issued in partnership with the Global Health Council, PATH, and the American Academy of Pediatrics, also welcomes the establishment of the Global Antimicrobial Surveillance System and urges WHO to monitor progress by member states in implementing national AMR actions plans to promote accountability.

PDF
GHTC, PATH, GHC
GHTC delivers statement on R&D for epidemic disease at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) highlighting the critical role new tools play in epidemic preparedness. The statement, issued in partnership with the Global Health Council and PATH, calls on the World Health Organization and member states to support regulatory capacity building and harmonization efforts, as well as coordinated approaches to develop new technologies through entities like the Coalition for Epidemic Preparedness.

PDF
GHTC
GHTC issues statement on WHO R&D observatory, pooled fund at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session supporting the rapid establishment and full funding for the World Health Organization (WHO) Global Observatory on Health Research and Development, as well as ongoing efforts to establish a pooled fund. The statement, issued with PATH, also calls for transparency to ensure the fund’s foundation is sound science and public health.

PDF
GHTC
GHTC issues statement on antimicrobial resistance at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the World Health Organization’s (WHO) efforts to combat antimicrobial drug resistance (AMR). The statement, issues with PATH, calls on the US government to support these efforts, with a focus on prioritizing development of a range of new tools, as well as to support the establishment of the Global Antimicrobial Surveillance System.

PDF
GHTC
GHTC issues statement on R&D for epidemic diseases at HHS WHA listening session

GHTC issued a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session highlighting the critical role new tools play in epidemic preparedness. The statement, issued with PATH, calls on the US government to support regulatory capacity building and harmonization efforts with the World Health Organization and efforts by the Coalition for Epidemic Preparedness, as well as notes the necessity of developing affordable and available tools in order to combat potentially epidemic diseases in low-resource settings, where outbreaks most often occur.

PDF
PATH/Gabe Bienczycki
Global health coalition urges G20 pledge on pandemics and neglected diseases

A coalition of global health organizations, including GHTC, has called on the G20 to provide leadership in combating pandemics, drug resistance, and major poverty-related and neglected diseases.

Learn More
GHTC sends FY18 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2018 (FY18) budget.

Learn More
CDC Coalition
GHTC signs letter to House and Senate appropriators calling for robust CDC funding

GHTC endorsed a letter from the CDC Coalition urging House and Senate appropriators to provide robust funding for the US Centers for Disease Control and Prevention (CDC) in the fiscal year 2018 budget.

PDF
GHTC submits letter to WHO urging approval of proposal for an essential diagnostics list

GHTC submitted a letter to the World Health Organization’s (WHO) Committee on the Selection and Use of Essential Medicines calling for it to approve the proposal to create an essential diagnostics list to complement the essential medicines list (EML). The letter, signed by 12 GHTC members, notes the impact that the EML has had on improving access to medicines and details the ways in which a diagnostics list would have similar impact.

PDF
GHTC issues statement on CEWG follow-up, R&D observatory at WHO Executive board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board welcoming progress by WHO in operationalizing a Global Observatory on Health Research and Development as a follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The statement, which was issued in partnership with the Global Health Council, also encouraged member states to fully fund the observatory and recommended diverse global health stakeholders be consulted as the process moves forward.

PDF
GHTC issues statement on antimicrobial resistance at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board supporting the assembly’s resolution on antimicrobial resistance (AMR), which incorporates R&D as a vital part of WHO’s strategy to combat AMR. The statement also calls for WHO to accelerate efforts to develop accountability frameworks to ensure AMR commitments are realized. The statement was issued in partnership with the Global Health Council and PATH.

PDF
GHTC issues statement on R&D for epidemic diseases at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.

PDF
GHTC sends letter urging WHO to establish an essential diagnostics list

GHTC sent a letter to the World Health Organization's (WHO) Assistant Director-General of Health Systems and Innovation urging WHO to support the establishment of an essential diagnostics list.

PDF
GHTC sends FY18 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the incoming president to prioritize global health R&D in his or her fiscal year 2018 (FY18) budget.

PDF
GHTC sends letter urging Senate to oppose provisions in Defense Authorization Act which could threaten medical research

GHTC sent a letter to members of the Senate Armed Services Committee and members of the Senate Appropriations Subcommittee on Defense urging them to oppose provisions in the fiscal year 2017 National Defense Authorization Act that would threaten medical research at the US Department of Defense.

PDF
GHTC sends FY17 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to prioritize global health R&D in the fiscal year 2017 (FY17) budget.

Learn More
GHTC sends letter urging Congress to commit to sustainable global health R&D financing, approve emergency Zika request

GHTC sent a letter to all 535 Members of Congress, urging them to commit to a long-term vision for financing global health research that ensures we have the tools necessary to treat both endemic and emerging diseases, like Zika.

PDF
GHTC submits letter to UN High-Level Panel on Access to Medicines

GHTC sent a letter to the UN Secretary General and submitted evidence to the High-Level Panel (HLP) urging them to incorporate the experience of product development partnerships (PDPs), which demonstrate a variety of barriers to access to health technologies.

PDF
GHTC sends letter welcoming new USAID Administrator Gayle Smith

GHTC sent a letter welcoming incoming Administrator of the US Agency for International Development (USAID) Gayle Smith, highlighting the agency’s work on global health R&D and urging her to continue to support this work as administrator. 

PDF
GHTC and global health community sends letter to House sponsors of Global Health Innovation Act

GHTC and members of the global health community sent a letter to Representatives Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL), thanking them for sponsoring the Global Health Innovation Act (HR 2241) and highlighting the importance of the US Agency for International Development's annual report on health-related R&D.

PDF
GHTC sends FY17 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for President Obama to prioritize global health R&D in his fiscal year 2017 (FY2017) budget.

PDF
GHTC sends FY16 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees urging them to prioritize global health R&D in the fiscal year 2016 (FY16) budget.

Learn More
GHTC sends FY16 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget, urging President Obama to prioritize global health R&D in his fiscal year 2016 (FY16) budget.

PDF

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide